Two years after AstraZeneca splashed out $1 billion upfront for rights to Daiichi Sankyo's TROP2-targeting antibody-drug conjugate DS-1062, the drug has generate promising results in advanced ...

Antibody-drug conjugates are receiving unrivaled attention across the biopharma sector. Fueled by Enhertu’s tumor-agnostic accelerated approval, practice changing combination results from Seagen and ...

An oscilloscope is usually the most sensitive, and arguably most versatile, tool on a hacker’s workbench, often taking ...

This price reflects trading activity during the overnight session on the Blue Ocean ATS, available 8 PM to 4 AM ET, Sunday through Thursday, when regular markets are closed.

It can be used for chip evaluation, program pre-research and personal DIY, and can be applied to product forms such as game consoles, smart commercial displays, HMI, and smart central control. D1s is ...